Governments need better guidance to maximise value for money: the case of Australia’s Pharmaceutical Benefits Advisory Committee

12 July 2016 - In Australia, the PBAC makes recommendations to the Minister for Health on which pharmaceuticals should be ...

Read more →

Drug that cures rare disease hereditary tyrosinaemia type 1 gets approval on Life Saving Drugs Program

9 July 2016 - Six weeks after the birth of their daughter Jeanette in 2001, Melbourne couple Faye and Youssef Azer ...

Read more →

Rare Cancers Australia lodges PBAC submission

8 July 2016 - Rare Cancers Australia has lodged a submission for the reimbursement of MSD's Zolinza (vorinistat) for cutaneous T-cell ...

Read more →

Election 2016: 'Mediscare' makes Medicare reform harder

3 July 2016 - The success of Labor's Medicare scare campaign makes it more difficult for a Coalition or Labor government ...

Read more →

Public Summary Documents - March 2016 PBAC meeting

1 July 2016 - The Public Summary Documents (recommendations and subsequent decisions not to recommend) from the March 2016 PBAC meeting ...

Read more →

Schedule of Pharmaceutical Benefits - 1 July 2016 update

1 July 2016 - The July 2016 issue of the Schedule of Pharmaceutical Benefits does not include the listing of ...

Read more →

Updated price disclosure arrangements procedural and operational guidelines

29 June 2016 - Updated price disclosure arrangements procedural and operational guidelines are now available. ...

Read more →

Experimental immunotherapy drug reduces rare tumour size 'dramatically'

24 June 2016 - An experimental immunotherapy drug treatment has significantly reduced the size of a critically ill 36-year-old woman's rare ...

Read more →

PBS hospital medication charts

24 June 2016 - The PBS Hospital Medication Chart Project aims to improve the safety of medication management in Australian hospitals ...

Read more →

Removal of blood glucose test strips from the PBS on 1 July 2016

21 June 2016 - From 1 July 2016 blood glucose test strips will no longer be available on the PBS. ...

Read more →

Notification of outcomes for the 2016 October cycle of price disclosure

20 June 2016 - The Minister’s delegate will consider making the weighted average disclosed price determination for the 2016 October Cycle ...

Read more →

Valuing the benefits of new anti-cancer drugs

20 June 2016 - Improvements in survival and cancer-related symptoms must be weighed up against treatment-related adverse effects and financial burden. ...

Read more →

Cancer patients hurt by lack of informed choice on costs, options

20 June 2016 - Doctors who are not upfront with cancer patients about likely out-of-pocket costs and other options are causing ...

Read more →

Political parties commit support for community pharmacy model

17 June 2016 - With 17 days until the Federal election, the pharmacy and broader health policies of the political parties ...

Read more →

Section 100 IVF Program - updated claiming arrangements

17 June 2016 - From 1 July 2016, approved suppliers will be required to submit a Reproductive Technology Accreditation Committee (RTAC) ...

Read more →